SR

Sangeeta Rani

Director Director DIN 01105054
DIN 01105054 First appointment Nov 2005 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Nov 2005
Shareholding value Locked Premium profile

About Sangeeta Rani

Data last updated:

Sangeeta Rani has 20 years in corporate governance. Formerly with 1 company, such as Biotropics Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01105054
Primary Designation Director
First Appointment 16 Nov 2005
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Biotropics Pharma Private Limited U74899DL2001PTC109299
Director16 Nov 20052001Under Liquidation

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Biotropics Pharma Private Limited
Premium access

Shareholding and investment profile for Sangeeta Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangeeta Rani

Sangeeta Rani has 20 years in corporate governance. Formerly with 1 company, such as Biotropics Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Sangeeta Rani is associated with 0 companies as a director.

Sangeeta Rani has expertise in General Business.

Sangeeta Rani has 20 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available